|
Volume
28 Number 5
31 May 2016
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
18, Year 2016 >
Number 5, 31 May
|
|
|
|
|
|
Cihan
YB.
Role
of Re-irradiation in Salvage Treatment of Glioblastoma
Multiforme.
Asian
Pac J Cancer Prev. 2016 May, 2016;17(5):2729-30→.
PMID: 27268660→.
Letter
to the Editor. ˍ
|
|
|
|
Koschmann
C, Bloom K, Upadhyaya S, Geyer JR, Leary SE.
Survival
After Relapse of Medulloblastoma.
J
Pediatr Hematol Oncol. 2016 May;38(4):269-73→.
doi: 10.1097/MPH.0000000000000547→.
PMID: 26907655→.
Observational
study; ˍ
|
|
|
|
Lafay-Cousin
L, Smith A, Chi SN, Wells E, Madden J, Margol A, Ramaswamy V,
Finlay J, Taylor MD, Dhall G, Strother D, Kieran MW, Foreman NK,
Packer RJ, Bouffet E.
Clinical,
Pathological, and Molecular Characterization of Infant
Medulloblastomas Treated with Sequential High-Dose
Chemotherapy.
Pediatr
Blood Cancer.
2016 May 4. 2016;63(9):1527-34→.
doi: 10.1002/pbc.26042→.
PMID:
27145464→.
Observational study. ˍ
Erratum
in:
Pediatr
Blood Cancer. 2017 Jan 4. 2017;64(4):e26435→.
doi: 10.1002/pbc.26435→.
PMID: 28221730→
Correction.
ˍ
|
|
|
|
Pajtler
KW, Tippelt S, Siegler N, Reichling S, Zimmermann M, Mikasch R,
Bode U, Gnekow A, Pietsch T, Benesch M, Rutkowski S, Fleischhack
G.
Intraventricular
etoposide safety and toxicity profile in children and young adults
with refractory or recurrent malignant brain tumors.
J
Neurooncol. 2016 May 4, 2016;128(3):463-71→.
doi: 10.1007/s11060-016-2133-x→.
PMID: 27147083→.
Interventional study. ˍ
|
|
|
|
Schneider
H, Weller M.
Boswellic
acid activity against glioblastoma stem-like cells.
Oncol
Lett. 2016 May 4, 2016;11(6):4187-4192→.
doi: 10.3892/ol.2016.4516→.
PMID: 27313764→
Laboratory
investigation. ˍ
|
|
|
|
Ene
CI, Nerva JD, Morton RP, Barkley AS, Barber JK, Ko AL, Silbergeld
DL.
Safety
and efficacy of carmustine (BCNU) wafers for metastatic brain
tumors.
Surg
Neurol Int. 2016 May 6, 2016;7(Suppl 11):S295-9→.
doi: 10.4103/2152-7806.181987→.
PMID: 27217968→.
Observational study. ˍ
|
|
|
|
Carter
T, Shaw H, Cohn-Brown D, Chester K, Mulholland P.
Ipilimumab
and Bevacizumab in Glioblastoma.
Clin
Oncol (R Coll Radiol). 2016 May 8, 2016 Oct;28(10):622-626→.
doi: 10.1016/j.clon.2016.04.042→.
PMID: 27169593→.
Observational study. ˍ
|
|
|
|
Lee
J, Cho J, Chang JH, Suh CO.
Re-Irradiation
for Recurrent Gliomas: Treatment Outcomes and Prognostic
Factors.
Yonsei
Med J. 2016 May 10, 2016;57(4):824-30→.
doi: 10.3349/ymj.2016.57.4.824→.
PMID: 27189273→.
Observational study. ˍ
|
|
|
|
Samal
F, Stanek L, Filip M, Haninec P, Vícha A, Musil Z, Tesarova
P, Petruzelka L, Springer D, Kralickova M, Kohoutova M, Zima T.
Complete
diagnostics and clinical approach for a female patient with
unusual glioblastoma: A case study.
Mol
Clin Oncol. 2016 May 10, 2016;5(1):161-164→.
doi: 10.3892/mco.2016.891→.
PMID: 27330791→.
Case report. ˍ
|
|
|
|
Lombardi
G, Bellu L, Pambuku A, Della Puppa A, Fiduccia P, Farina M,
D'Avella D, Zagonel V.
Clinical
outcome of an alternative fotemustine schedule in elderly patients
with recurrent glioblastoma: a mono-institutional retrospective
study.
J
Neurooncol. 2016 May 11, 2016;128(3):481-6→.
doi: 10.1007/s11060-016-2136-7→.
PMID: 27165580→.
Observational study. ˍ
|
|
|
|
Cha
Y, Kim YJ, Lee SH, Kim TM, Choi SH, Kim DW, Park CK, Kim IH, Kim
JH, Kim E, Choi B, Kim CY, Kim IA, Heo DS.
Post-bevacizumab
Clinical Outcomes and the Impact of Early Discontinuation of
Bevacizumab in Patients with Recurrent Malignant Glioma.
Cancer
Res Treat. 2016 May 18, 2017;49(1):129-140→.
doi: 10.4143/crt.2015.466→.
PMID: 27188199→.
Observational study. ˍ
|
|
|
|
Liu
HL, Hsu PH, Lin CY, Huang CW, Chai WY, Chu PC, Huang CY, Chen PY,
Yang LY, Kuo JS, Wei KC.
Focused
Ultrasound Enhances Central Nervous System Delivery of Bevacizumab
for Malignant Glioma Treatment.
Radiology.
2016 May 18, 2016;281(1):99-108→.
doi: 10.1148/radiol.2016152444→.
PMID: 27192459→.
Laboratory
investigation. ˍ
|
|
|
|
Schaub
C, Tichy J, Schäfer N, Franz K, Mack F, Mittelbronn M, Kebir
S, Thiepold AL, Waha A, Filmann N, Banat M, Fimmers R, Steinbach
JP, Herrlinger U, Rieger J, Glas M, Bähr O.
Prognostic
factors in recurrent glioblastoma patients treated with
bevacizumab.
J
Neurooncol. 2016 May 18, 2016;129(1):93-100→.
doi: 10.1007/s11060-016-2144-7→.
PMID: 27193554→.
Observational study. ˍ
|
|
|
|
Cheng W, Ren X, Zhang C, Cai J, Liu
Y, Han S, Wu A.
Bioinformatic
profiling identifies an immune-related risk signature for
glioblastoma.
Neurology.
2016 May 25, 2016;86(24):2226-34→.
doi: 10.1212/WNL.0000000000002770→.
PMID: 27225222→.
Laboratory investigation. _
|
|
|
|
Brown
N, McBain C, Nash S, Hopkins K, Sanghera P, Saran F, Phillips M,
Dungey F, Clifton-Hadley L, Wanek K, Krell D, Jeffries S, Khan I,
Smith P, Mulholland P.
Multi-Center
Randomized Phase II Study Comparing Cediranib plus Gefitinib with
Cediranib plus Placebo in Subjects with Recurrent/Progressive
Glioblastoma.
PLoS
One. 2016 May 27;11(5):e0156369→.
doi: 10.1371/journal.pone.0156369→.
PMID:
27232884→.
Interventional
study. ˍ
|
|
|
|
|
|
|
|
|
